BCYC Q4 2024 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-30.4% YoY

Gross Profit

-$52M-1412.2% margin

Operating Income

-$68M-1824.8% margin

Net Income

-$52M-1398.4% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+38.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$957M

Total Liabilities

$164M

Stockholders' Equity

$793M

Cash & Equivalents

$880M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-30.4%
Gross Profit	-$52M	$5M	-1082.3%
Operating Income	-$68M	-$54M	-24.8%
Net Income	-$52M	-$49M	-5.6%